Patents by Inventor Veronika Pape

Veronika Pape has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MDR-reversing 8-hydroxy-quinoline derivatives
    Patent number: 10744127
    Abstract: The present invention is related to 8-hydroxy-quinoline derivatives having multidrug-resistance reversing activity with improved selectivity and increased cytotoxicity towards multidrug-resistant cancer cells, preparation thereof and use of the same in the treatment of cancer, especially multidrug-resistant variants thereof.
    Type: Grant
    Filed: April 5, 2017
    Date of Patent: August 18, 2020
    Assignee: Magyar Tudományos Akadémia Természettudományi Kutatóközpont
    Inventors: Gergely Szakács, Tibor Soós, Roberta Ferenczi-Palkó, András Füredi, Szilárd Tóth, Dóra Türk, Veronika Pape, Ferenc Fülöp, István Szatmári, György Dormán
  • MDR-REVERSING 8-HYDROXY-QUINOLINE DERIVATIVES
    Publication number: 20190151306
    Abstract: The present invention is related to 8-hydroxy-quinoline derivatives having multidrug-resistance reversing activity with improved selectivity and increased cytotoxicity towards multidrug-resistant cancer cells, preparation thereof and use of the same in the treatment of cancer, especially multidrug-resistant variants thereof.
    Type: Application
    Filed: April 5, 2017
    Publication date: May 23, 2019
    Applicant: Magyar Tudományos Akadémia Természettudományi Kutatóközpont
    Inventors: Gergely SZAKÁCS, Tibor SOÓS, Roberta FERENCZI-PALKÓ, András FÜREDI, Szilárd TÓTH, Dóra TÜRK, Veronika PAPE, Ferenc FÜLÖP, István SZATMÁRI, György DORMÁN
  • COMPOUNDS AS PPAR BETA/DELTA INHIBITORS FOR TREATING PPAR BETA/DELTA-MEDIATED DISEASES
    Publication number: 20150018411
    Abstract: The present invention concerns substances which act as selective ligands of nuclear receptors of the PPAR beta/delta subtype and which can be used for the treatment of PPAR beta/delta-mediated diseases. The substances of this invention act as inhibitors of PPAR beta/delta receptors.
    Type: Application
    Filed: June 6, 2012
    Publication date: January 15, 2015
    Applicant: PHILIPPS-UNIVERSITAT MARBURG
    Inventors: Wibke Diederich, Stefanie Dorr, Kerstin Kaddatz, Gerhard Klebe, Rolf Muller, Simone Naruhn, Veronika Pape, Josefine Stockert, Philipp Manuel Toth